Best Supplements to Take With SS-31

SS-31 Fixes the Mitochondrial Engine. These Supplements Keep It Running.

Most mitochondrial support supplements work by catching reactive oxygen species after they have already been produced. They are cleanup crews. SS-31 does something fundamentally different: it targets cardiolipin, a phospholipid found nowhere else in the body except the inner mitochondrial membrane, and stabilizes the protein complexes that generate ATP in the first place. That is an upstream intervention, and it changes what the body needs around it.

Cardiolipin is structural. Think of it as the scaffolding that holds your cell's power plant in its correct shape. When cardiolipin degrades, the electron transport chain, the sequence of protein complexes that converts food energy into usable ATP, begins to leak. Electrons escape before completing their intended path, producing damaging byproducts instead of energy. SS-31 anchors that scaffolding back in place, stopping the leak at its source rather than mopping up the byproducts downstream.

That mechanism is not receptor-based. It is biophysical. SS-31 carries an alternating arrangement of charged and aromatic amino acids that allows it to concentrate inside mitochondria at levels far exceeding what is circulating in the bloodstream, driven by the mitochondria's own electrical gradient. Once there, it binds cardiolipin electrostatically, preserving the architecture of the electron transport chain and protecting a protein called cytochrome c from switching roles. Normally cytochrome c shuttles electrons toward ATP production. When the inner membrane is damaged, it converts into a damaging enzyme that tears the membrane further and signals cell death. SS-31 keeps it in the shuttling role.

Here is what that means in practice. SS-31 optimizes the structural efficiency of your existing mitochondrial machinery. It does not generate the raw materials that machinery runs on. It does not replace the iron that cytochromes require to carry electrons. It does not supply the NAD+ that Complex I needs as its primary substrate. It does not ensure that the ATP being produced can actually be used, which requires magnesium. Any of those gaps left open is a ceiling SS-31 cannot raise, no matter how well it stabilizes what is already there.

This is the case for the supplements that follow. They are not generic mitochondrial health entries. Each one addresses a specific, mechanistically defined requirement created by what SS-31 is actually doing inside the cell.

The Supplements That Matter Most Alongside SS-31

There are no dose numbers on this page. The right amount of each of these depends on your actual SS-31 protocol, your current bloodwork, and what else you are already taking. Individual factors, especially ferritin and RBC magnesium levels, can shift the picture substantially. The MyPeptidePal app works out those personalized amounts from your specific inputs.

What the SS-31-Optimized Machinery Cannot Run Without

SS-31 stabilizes the electron transport chain's architecture. What moves through that architecture once it is stabilized still depends on the specific molecules that carry out each step. Three of them represent genuine rate-limiting constraints.

CoQ10

Coenzyme Q10 is an electron carrier. Its job is to pick up electrons from Complex I and Complex II, the first two stages of the electron transport chain, and hand them off to Complex III. Without that handoff, the chain stalls regardless of how well its structure has been maintained. SS-31's stabilizing work has nowhere to go.

SS-31 and CoQ10 are not doing the same job. SS-31 protects the structural scaffolding that keeps the complexes in their correct configuration. CoQ10 is the molecule that physically moves electrons between those complexes. A well-maintained conveyor belt with nothing to carry is still a conveyor belt that produces nothing. CoQ10 also functions as a lipid-phase antioxidant within the inner membrane, catching oxidative damage that slips past SS-31's upstream prevention. Those are genuinely distinct, additive roles, which is why CoQ10 qualifies as a double-duty addition on this stack.

One practical note: CoQ10 causes nausea or gastrointestinal discomfort in roughly 14 to 20 percent of people, and this tends to persist longer than the transient nausea SS-31 itself produces in a smaller fraction of users. If you are stacking both and experiencing GI symptoms, CoQ10 is the more likely persistent source. The ubiquinol form is better absorbed than ubiquinone, particularly in older adults.

The clinical evidence for CoQ10 is strongest in people with mitochondrial disease and heart failure. In otherwise healthy people, the evidence is more mixed, meaning the benefit is mechanistically coherent and plausible but has not been demonstrated cleanly in controlled trials in that population.

PQQ

Pyrroloquinoline quinone takes a different route than CoQ10. Its primary relevance here is mitochondrial biogenesis, the cellular process that creates new mitochondria. SS-31 works on the mitochondria you already have. PQQ helps determine how many of them you have to work with.

The protein that triggers new mitochondria to form is called PGC-1 alpha, which acts as the master switch for mitochondrial biogenesis. PQQ activates signaling pathways that increase PGC-1 alpha activity. More mitochondria means a larger total surface area for SS-31 to act on and a greater energy-generating capacity overall. PQQ also functions as a redox cofactor, cycling between oxidized and reduced states to participate directly in electron transfer.

The evidence base here is smaller than for CoQ10, drawing primarily from cell studies and a modest number of human trials. The mechanistic logic holds up well; the clinical translation is still being established. This one is best characterized as mixed evidence.

L-Carnitine

L-Carnitine does not act on the electron transport chain directly. It acts one step upstream: it is the essential transporter that carries long-chain fatty acids across the inner mitochondrial membrane so they can enter the chain as fuel.

Fats are the mitochondria's preferred fuel source during sustained, low-to-moderate intensity activity. They cannot cross the inner membrane on their own. L-Carnitine is the dedicated carrier molecule that moves them in. A well-structured, SS-31-stabilized electron transport chain without an adequate supply of transported fatty acids is an engine running on a restricted fuel supply by default.

Carnitine shortfalls are more common than most people realize, particularly in older adults, in people who eat little or no red meat, and under significant metabolic stress. The clinical evidence for L-Carnitine is strongest in people with confirmed carnitine deficiency, heart failure, and age-related muscle loss. In people with adequate carnitine status, the incremental benefit is less pronounced.

Deficiencies That Create a Hard Floor Under Your Results

These two are not about optimization. They are about removing a constraint that prevents SS-31's mechanism from executing fully. If either is deficient, the compound is working against a limitation it was not designed to work around.

Iron

Iron is structural to the electron transport chain in a way most supplements are not. The cytochromes that carry electrons through Complexes III and IV, and the iron-sulfur cluster proteins embedded in Complexes I, II, and III, are all built around iron. These are not optional support structures. They are the functional machinery of the chain itself.

SS-31 protects the organization of these complexes by stabilizing cardiolipin. But if iron deficiency means the cytochromes themselves are underbuilt or underperforming, that structural protection has less to work with. The scaffolding is maintained, but the working parts inside it are compromised. That is not a problem SS-31 can solve, because the problem is one level below where SS-31 operates.

The right marker to check is ferritin, which reflects iron stores rather than just the iron circulating in your blood at a given moment. A normal serum iron reading with low ferritin is a meaningful finding that standard panels sometimes miss entirely. Functional practitioners generally target ferritin above 70 micrograms per liter for optimal mitochondrial performance, which sits well above the laboratory minimums many reference ranges use.

One caution worth stating clearly: high-dose iron supplements can generate oxidative reactions inside mitochondria, which would work against SS-31's mechanism of reducing reactive oxygen species. Iron is one of the few nutrients where more is not better if you are not deficient. Use it only to correct a confirmed shortfall, and separate it from your SS-31 injection when you do.

Magnesium

ATP, the energy currency SS-31 is helping your mitochondria produce more of, does not function in its free form inside cells. Almost every enzyme that uses ATP requires it bound to magnesium first, producing what is called Mg-ATP. Without that binding step, the increased ATP output from better mitochondrial function cannot be utilized downstream. The improvement is real and measurable at the mitochondria and inaccessible everywhere else.

Magnesium shortfalls are common and consistently underestimated. The standard serum magnesium test does not reflect intracellular stores accurately. The body keeps serum magnesium within a narrow range even when tissue-level depletion is significant, so a normal result on a routine panel does not rule out functional deficiency. RBC magnesium, which measures the mineral inside red blood cells rather than in serum, is the more meaningful test and the one worth requesting.

Magnesium also matters for a secondary reason specific to this stack. It is required to convert vitamin D into its active forms in the body. If vitamin D status is being addressed alongside SS-31 because of its role in mitochondrial biogenesis, inadequate magnesium will blunt that correction. The two are connected.

Glycinate and malate are better-tolerated forms for supplementation, producing fewer GI effects than oxide or chloride at equivalent doses.

Pathways That Amplify What SS-31 Is Already Building

These two do not fix a deficiency or supply a missing structural component. They push toward the same outcome, better mitochondrial energy output, through mechanisms that do not overlap with SS-31's. The result of combining them is more than either produces alone.

NAD+ Precursor (NMN)

NAD+ (nicotinamide adenine dinucleotide) is the electron carrier that Complex I of the electron transport chain runs on. Complex I accepts high-energy electrons from NAD+ and begins the cascade that ultimately produces ATP. Without an adequate NAD+ supply, there are no electrons to shuttle through the chain that SS-31 has stabilized.

The analogy holds precisely: SS-31 tunes the engine. NAD+ precursors fuel it. These are genuinely non-overlapping mechanisms, and neither substitutes for the other.

NAD+ levels decline with age, with metabolic stress, and with chronic inflammation. This decline is one of the mechanisms researchers think underlies age-related mitochondrial dysfunction. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) both raise cellular NAD+ pools. The preclinical evidence for both is compelling. Human trial evidence as of 2026 is building but not yet definitive for longevity outcomes; data for energy, muscle function, and metabolic markers is more supportive. This is genuinely mixed evidence, and it would be inaccurate to describe it otherwise.

The complementarity with SS-31 is mechanistically well-reasoned even though the specific combination has not been put through a randomized controlled trial. What exists is a coherent, non-redundant mechanism and preclinical support.

Alpha-Lipoic Acid

Alpha-lipoic acid is an antioxidant that is active specifically inside the mitochondrial environment. That specificity is what makes it relevant here rather than as a general antioxidant entry.

SS-31 prevents reactive oxygen species from being produced in excess by keeping electrons on their intended path. Alpha-lipoic acid operates downstream of that: it catches the oxidative byproducts that do form, including those from normal metabolic activity rather than electron leakage. These two mechanisms work in sequence. SS-31 reduces the source; alpha-lipoic acid manages what gets through.

Alpha-lipoic acid also participates in regenerating vitamins C and E, and acts as a cofactor for enzymes in the central energy pathway. The clinical evidence is strongest in people with diabetic neuropathy and metabolic syndrome. Its specific combination with SS-31 is supported by mechanism and community use rather than a dedicated human trial.

Cautions and Interactions

Nephrotoxic Medications Require Medical Supervision

This is the interaction that warrants the most attention. SS-31 is cleared by the kidneys. Any medication that impairs kidney function can cause it to accumulate rather than clear, increasing exposure in ways that have not been studied. Drugs in this category include aminoglycoside antibiotics, NSAIDs taken regularly at therapeutic doses, and certain chemotherapy agents including cisplatin. Cyclosporine, an immunosuppressant, carries a further specific concern: it interacts with a structure in the mitochondria called the permeability transition pore, which SS-31 may also affect through a separate route. Combining two compounds acting on that structure via different mechanisms is genuinely unstudied. Do not combine SS-31 with nephrotoxic medications or cyclosporine without a prescribing clinician managing both.

Iron Dosing

High-dose iron supplementation at levels above what correcting a genuine deficiency requires can generate oxidative reactions inside mitochondria that work against SS-31's mechanism. This is not a reason to avoid iron when ferritin is genuinely low; correcting that shortfall matters more than avoiding a theoretical overlap at therapeutic doses. It is a reason to test ferritin first, use only what is needed to address a confirmed shortfall, and space iron doses away from your SS-31 injection.

CoQ10 and GI Symptoms

CoQ10 causes nausea or GI distress in roughly 14 to 20 percent of people, and this typically persists longer than SS-31's own transient nausea, which resolves in most users within one to two weeks. When stacking both, do not assume GI symptoms are coming exclusively from SS-31. CoQ10 is the more persistent source. Taking it with food and splitting the dose across the day typically reduces this.

Cardiotoxic Agents

If you are being treated with a medication that affects cardiac tissue, such as certain chemotherapy drugs or targeted therapies, SS-31 may modify mitochondrial markers in the heart in ways that complicate interpretation of standard monitoring. This warrants prescriber awareness. Raise it with your physician before combining.

High-Dose Stimulant Supplements

Stacking SS-31 with aggressive stimulant formulations compounds the demand on the nervous system and on mitochondrial output simultaneously. No pharmacological interaction is known, but the practical effect is a higher total stimulation load than either produces alone. Monitor how you respond, particularly early in the protocol.

Frequently Asked Questions

How much of each supplement should I take with SS-31?

There are no dose numbers on this page, and that is deliberate. The right amount of CoQ10, iron, magnesium, NMN, or any other supplement on this list depends on your specific SS-31 protocol, your current bloodwork (particularly ferritin and RBC magnesium), and everything else you are currently taking. The MyPeptidePal app takes those inputs and builds a personalized plan from them. A number printed for an average person would be wrong for most specific ones.

Which blood markers actually matter when running SS-31?

Ferritin and RBC magnesium are the two most actionable markers to check before you start, because both represent common shortfalls that set a hard floor under your results. Creatine kinase and lactate are worth tracking over the course of a cycle: SS-31 should reduce both, and if they are not falling, it may point to a substrate bottleneck, most commonly iron or NAD+. Plasma CoQ10 is measurable if you want to confirm adequate levels before stacking. Whole-blood NAD+ can be checked if you are running NMN and want to verify it is working.

Does taking all of these supplements reduce how well SS-31 works?

For most of the list, no. CoQ10, NMN, magnesium, alpha-lipoic acid, and L-carnitine all work through mechanisms that complement SS-31 rather than competing with it. The one partial exception is high-dose iron, which at supraphysiologic levels can generate oxidative activity inside mitochondria that partially counters SS-31's work. That concern does not apply at therapeutic doses used to correct a genuine deficiency. The cautions section has the detail.

Can I just eat well and skip the supplements?

For some of these, yes. L-Carnitine appears in red meat at meaningful concentrations, and dietary CoQ10 provides a real baseline contribution. For others, diet has real limits. NAD+ precursors at levels that measurably raise cellular NAD+ pools are difficult to reach through food alone. Magnesium is widely underconsumed in most modern diets, and the gap widens with higher activity levels or stress. Iron depends entirely on your starting ferritin, which can be low for reasons that diet alone takes months to fully correct. Eating well is a prerequisite, not a substitute.

Does SS-31 work differently from other mitochondrial peptides, and does that change the stack?

Yes, in a way that directly shapes this list. SS-31 works biophysically, by anchoring a lipid in the inner mitochondrial membrane, rather than through receptor binding or signaling cascades. MOTS-c, which is often grouped alongside it, works via AMPK activation and has meaningful effects on insulin sensitivity and glucose uptake that SS-31 does not share. Humanin works through a cell-surface receptor complex and activates cytokine-like signaling pathways. Neither of those involves cardiolipin or ETC architecture in the way SS-31 does. The practical consequence is that SS-31's stack is built around substrate supply (iron for cytochromes, NAD+ for Complex I, carnitine for fuel transport) and structural support for its specific membrane-targeting mechanism, rather than the receptor-sensitizing or signaling-pathway angles that would be more relevant for those other compounds.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and user-reported experience with SS-31 and the nutrients that support it in one place.